Monte Rosa Therapeutics, Inc.

GLUE

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001826457

SEC filings (opens in a new tab)

In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.

Q3 2025 vs. Q2 2025

How the institutions holding Monte Rosa Therapeutics, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of GLUE: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Q3 2025	Change
Holders	116	129	+13
Shares	62.2M	60.0M	−2.17M (−3.5%)
Value	$280.6M	$444.9M	+$164.3M (+58.6%)

New holders (27)

Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to GLUE in Q3 2025
Institution	Shares	Value	% of portfolio
Vestal Point Capital, LP	800,000	$5.93M	0.27%
Silverarc Capital Management, LLC	694,942	$5.15M	0.75%
Balyasny Asset Management LLC	408,540	$3.03M	0.01%
Jane Street Group, LLC	307,049	$2.28M	0.00%
ADAR1 Capital Management, LLC	215,752	$1.60M	0.16%
Macquarie Group Ltd	200,000	$1.48M	0.00%
JBF Capital, Inc.	148,566	$1.10M	0.16%
Rangeley Capital, LLC	113,000	$837.3K	0.79%
Point72 Asset Management, L.P.	90,419	$670.0K	0.00%
Empowered Funds, LLC	87,450	$648.0K	0.01%
Campbell & CO Investment Adviser LLC	51,133	$378.9K	0.03%
D. E. Shaw & Co., Inc.	50,213	$372.1K	0.00%
Simplex Trading, LLC	33,113	$245.0K	0.01%
SRS Capital Advisors, Inc.	32,445	$240.4K	0.00%
Omers Administration Corp	28,300	$209.7K	0.00%
Allspring Global Investments Holdings, LLC	24,597	$182.3K	0.00%
Scientech Research LLC	16,254	$120.4K	0.04%
Virtu Financial LLC	11,952	$89.0K	0.00%
Engineers Gate Manager LP	10,871	$80.6K	0.00%
Prelude Capital Management, LLC	10,202	$75.6K	0.01%
Wealth Effects LLC	10,099	$74.8K	0.02%
Russell Investments Group, Ltd.	4,318	$32.0K	0.00%
Point72 Europe (London) LLP	591	$4.38K	0.00%
Optiver Holding B.V.	584	$4.33K	0.00%
Turning Point Benefit Group, Inc.	14	$105	0.00%
Bessemer Group Inc	34	$0	0.00%
Summit Wealth Group LLC	2,002	–	–

Sold out (14)

Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of GLUE in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Avoro Capital Advisors LLC	3,725,000	$16.8M
ExodusPoint Capital Management, LP	109,227	$493.0K
Hillsdale Investment Management Inc.	60,100	$271.1K
Integrated Quantitative Investments LLC	35,400	$159.7K
Stonepine Capital Management, LLC	30,000	$135.3K
UBS Asset Management Americas Inc	24,100	$108.7K
Sherbrooke Park Advisers LLC	21,867	$98.6K
Voya Investment Management LLC	12,958	$58.4K
Lazard Asset Management LLC	10,857	$48.0K
Brighton Jones LLC	10,559	$47.6K
Raymond James Financial Inc	1,200	$5.41K
Caitong International Asset Management Co., Ltd	1,066	$4.81K
Skopos Labs, Inc.	92	$415
GAMMA Investing LLC	80	$361